Archive

Category: Amy Abernethy

Futurecasting with Amy Abernethy: Verily, Real-World Data, Clinical Trials & Health Policy in 2022

By JESSICA DaMASSA, WTF HEALTH Insight on what’s ahead for the future of clinical research, real-world evidence, and personalized healthcare from none other than former FDA Principal Deputy Commissioner and current President of Verily Life Sciences’ Clinical Research Platforms, Amy Abernethy. Amy testified before Congress a few weeks ago to answer their questions about some […]

Verily adds to its clinical trials toolbox with acquisition of startup SignalPath

Verily’s recent moves have signaled the company’s interest in supporting decentralized clinical trials and real-world studies. Now the life sciences subsidiary of Alphabet is bolstering its capabilities in this these areas with the acquisition of startup SignalPath.